Home » Stocks » SENS

Senseonics Holdings, Inc. (SENS)

Stock Price: $1.89 USD -0.09 (-4.55%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Market Cap 808.76M
Revenue (ttm) 4.95M
Net Income (ttm) -175.17M
Shares Out 227.91M
EPS (ttm) -0.77
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $1.89
Previous Close $1.98
Change ($) -0.09
Change (%) -4.55%
Day's Open 1.88
Day's Range 1.78 - 2.03
Day's Volume 23,168,227
52-Week Range 0.35 - 5.56

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Senseonics will likely rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next five years once it receives FDA approval.

1 week ago - InvestorPlace

SENS stock is banking on an FDA approval for its diabetes sensor. However, you'll want to analyze the fundamentals before proceeding.

1 week ago - InvestorPlace

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous gl...

2 weeks ago - Business Wire

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

4 weeks ago - Zacks Investment Research

Is SENS stock really just another "meme stock"? After examining Senseonics' tech innovations, it's clear that this is a serious investment.

1 month ago - InvestorPlace

Senseonics (SENS) delivered earnings and revenue surprises of -9.09% and 12.72%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

1 month ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

1 month ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

1 month ago - Business Wire

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

1 month ago - Zacks Investment Research

GERMANTOWN, Md,--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

2 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

2 months ago - Business Wire

The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's k...

Other stocks mentioned: CLVS, DVAX, LCI, NAKD, OPK, PGEN, TXMD ...
2 months ago - Benzinga

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long...

2 months ago - Business Wire

Senseonics Holdings (SENS) has moved higher as of late, but there could definitely be trouble on the horizon for this company.

2 months ago - Zacks Investment Research

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long...

2 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and commercialization of a long...

2 months ago - Business Wire

Senseonics Holdings, Inc (AMEX: SENS) shares spiked nearly 87% in the regular and after-hour sessions on Tuesday. What Happened: The medical technology company said EmblemHealth, one of the largest not-...

2 months ago - Benzinga

The specialist in glucose monitoring is helping people with diabetes manage their health.

2 months ago - The Motley Fool

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of long-term, implantable continuous gluco...

2 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

3 months ago - Business Wire

Senseonics Holdings (SENS) stock is on the rise Friday with heavy trading despite a lack of news concerning the pharmaceutical company. The post SENS Stock Alert: 10 Things to Know Before Investing in S...

3 months ago - InvestorPlace

Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.

3 months ago - Zacks Investment Research

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous gl...

3 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

3 months ago - Business Wire

This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penny stocks?

Other stocks mentioned: BIOL, JAGX, TNXP
3 months ago - Benzinga

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

4 months ago - Zacks Investment Research

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

4 months ago - Zacks Investment Research

Senseonics has had a large win via the Ascensia Diabetes collaboration structure, that creates shareholder value with long-tailed returns. The Eversense device will benefit from Ascensia's large footpri...

5 months ago - Seeking Alpha

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Senseonics (SENS) delivered earnings and revenue surprises of -66.67% and -2.42%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

5 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

5 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

5 months ago - Business Wire

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

5 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous gl...

6 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous gluc...

6 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

7 months ago - Business Wire

Investors need to pay close attention to Senseonics (SENS) stock based on the movements in the options market lately.

7 months ago - Zacks Investment Research

Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Senseonics (SENS) delivered earnings and revenue surprises of 100.00% and -76.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

8 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

8 months ago - Business Wire

TOKYO and BASEL, Switzerland, Aug. 10, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc.

8 months ago - PRNewsWire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

8 months ago - Business Wire

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc.

8 months ago - Business Wire

NEW YORK, Aug. 3, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty cla...

8 months ago - PRNewsWire

Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

9 months ago - Zacks Investment Research

About SENS

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It ... [Read more...]

Industry
Diagnostics & Research
Founded
1996
CEO
Timothy Goodnow
Employees
82
Stock Exchange
NYSEAMERICAN
Ticker Symbol
SENS
Full Company Profile

Financial Performance

In 2020, SENS's revenue was $4.95 million, a decrease of -76.77% compared to the previous year's $21.30 million. Losses were -$175.17 million, 51.6% more than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for SENS stock is "Buy." The 12-month stock price forecast is 2.55, which is an increase of 34.92% from the latest price.

Price Target
$2.55
(34.92% upside)
Analyst Consensus: Buy